Biotech Values

[WorstLuck]

The customer isn't seeing the results that were promised while paying a premium so their not too happy. I'm not so sure if new pricing will be helpful at this point.

It's a 'your mileage may vary' situation. It's easier to criticize the premium sales approach a posteriori than a priori. There wasn't much pre-launch criticism IIRC.

The challenge now is to build a user base around the realities of what Daxy offers. Those that perceive greater benefit (cost, duration, whatever) are the market and the best source of advertising for future sales build. Pricing helps remove one obstacle. It can be done but it won't happen overnight. RVNC just needs to do better - better marketing, better education, better incentives if that is what is needed.